TxCell SA CEO Stéphane Boissel earned his money the day he decided to change the company's strategy, technology focus and in fact the overall organization.
TxCell: Regen Med Firm's CEO Starts From Scratch
Since becoming CEO of TxCell two years ago, Stéphane Boissel has reorganized the R&D plan, restructured and reduced the head count and put the company on the road to scalable manufacturing of CAR-T regulatory cells. And he has put strategic partnerships on the agenda. It is a big change from the situation 12 months ago, he told In Vivo during the Annual European Advanced Therapies Investor Day.